Both high and low uric acid levels tied to higher mortality

Both high and  low uric acid levels tied to higher mortality

(HealthDay)—Both high and low uric acid levels are associated with an increased risk of dying, according to a study published in the July issue of Arthritis & Rheumatology.

Sung Kweon Cho, M.D., Ph.D., from Sungkyunkwan University in Seoul, South Korea, and colleagues evaluated the association between uric levels and the risk of all-cause and cause-specific among 375,163 Korean adults over a range of uric acid levels using national health records (2002 to 2012).

The researchers found that over the study period (2,060,721.9 person-years), 2,020 participants died, with 287 cardiovascular disease (CVD)-related deaths and 963 cancer deaths. Both low and high uric acid levels were associated with increased all-cause, CVD, and cancer mortality. For all-cause mortality in the lowest uric acid categories (<3.5 mg/dL for men and <2.5 mg/dL for women) versus the sex-specific reference category, multivariable-adjusted hazard ratios were 1.58 and 1.80, respectively. For the highest uric acid categories (≥9.5 mg/dL for men and ≥8.5 mg/dL for women), the corresponding hazard ratios were 2.39 and 3.77.

"In this large cohort study of men and women, both low and high uric acid levels were predictive of increased mortality, supporting a U-shaped association between serum uric acid levels and adverse health outcomes," the authors write.


Explore further

High uric acid levels linked to greater mortality

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: Both high and low uric acid levels tied to higher mortality (2018, July 19) retrieved 29 January 2020 from https://medicalxpress.com/news/2018-07-high-uric-acid-tied-higher.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments